Conduction system pacing in congenital heart disease
Óscar Cano, MD, PhD,1,2 Gopi Dandamudi, MD,3 Robert D. Schaller, DO,4 Víctor Pérez-Roselló, MD,1 Hebert D. Ayala, MD,1 Maite Izquierdo, MD, PhD,1Joaquín Osca, MD, PhD,1 María-José Sancho-Tello, MD, MD,1 Joaquín Rueda, MD, PhD,1,2Eladio Ruiz, MD,1 Beatriz Insa, MD,1Luis Martínez-Dolz, MD, PhD,1,2 Pugazhendhi Vijayaraman, MD5
1 Electrophysiology Section, Adult Congenital Heart Disease Section and Paediatric Cardiology Section, Cardiology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
2 Centro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Spain
3 Cardiovascular Service Line, Cardiology, CHI-Franciscan Health System, Tacoma, Washington, USA.
4 Electrophysiology Section, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5 Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, USA.
Word count : 4986
Conflict of interest : Dr. Cano has received consultant fees from Medtronic and Boston Scientific. Dr. Schaller has received honoraria and/or research funding from Abbott, Biotronik, Boston Scientific, Medtronic, and Philips. Dr. Dandamudi has served as a speaker and consultant for Medtronic; and served onthe Advisory Board for Biotronik. Dr. Vijayaraman has received honoraria, been a consultant, conducted research, and received fellowship support from Medtronic; has been a consultant for Boston Scientific, Abbott, and Biotronik; and has a patent pending for the His bundle pacing delivery tool. All other authors have nothing to disclose.